1. Introduction {#sec1-marinedrugs-18-00198}
===============

Seaweeds are the 'lungs of the sea' as well as a potential 'wild pharmacy'. These plant like organisms produce 70--80% oxygen for the atmosphere and possess scads of metabolites with unique structures of medicinal values \[[@B1-marinedrugs-18-00198],[@B2-marinedrugs-18-00198]\]. In addition to their ecological importance, seaweeds have been a source of food for humans since ancient times. Seaweeds, also referred as algae, are commonly consumed as either fresh or dried in Asian, African and European countries. The consumption of seaweeds as food products can be traced back to the fourth century in Japan. Seaweeds are rich in vitamins A, E, C, B~1~ and B~12~, carbohydrates and organic iodine. The annual human consumption of algae in a dried form is estimated to be 2,000,000 tons \[[@B3-marinedrugs-18-00198]\]. In addition to their nutritive value, seaweeds are known to possess a wide array of valuable pharmacological properties including use as antibiotics, anticoagulants, antiulcer, antioxidants, antimicrobials, and antifouling \[[@B4-marinedrugs-18-00198],[@B5-marinedrugs-18-00198]\].

Nonetheless, there is still a dearth of scientific data on the pharmacological and chemical profiles of seaweeds. Therefore, the present study was designed to investigate the pharmacological and chemical profiles of five seaweeds originating from different families, namely *Halimeda* spp. (Family: Halimedaceae)*, Spyridia hypnoides* (Bory de Saint-Vincent) Papenfuss (Family: Spyridiaceae), *Valoniopsis pachynema* (G. Martens) Børgesen (Family: Valoniaceae), *Gracilaria fergusonii* J. Agardh (Family: Gracilariaceae) and *Amphiroa anceps* (Lamarck) Decaisne (Family: Lithophyllaceae) collected in Tamil Nadu, India. *Halimeda* is a well-known green algae made up of discs containing calcium carbonate \[[@B6-marinedrugs-18-00198]\]. Works of literature reported that *Halimeda* spp. has potential apoptosis, anti-inflammatory, antioxidant, neuroprotective and hepatoprotective properties \[[@B7-marinedrugs-18-00198]\]. *Spyridia hypnoides*, belonging to the family Spyridiaceae, is a 15 cm tall plant like organism with numerous branches at short intervals. No reproductive structures were observed in this seaweed \[[@B8-marinedrugs-18-00198]\]. Sudharsan et al. reported that the galactans isolated from *S. hypnoides* exhibited anticoagulant and antioxidant properties. *V. pachynema,* also known as AstroTurf algae, originates from the family Valoniaceae. It is a filamentous alga, spongy and tends to cover completely the surface (dead corals, rocks) on which it grows to form a ball-like appearance \[[@B9-marinedrugs-18-00198]\]. A study conducted by Kumar et al. reported high level of calcium (476.67 ± 6.2%) in this seaweed species \[[@B10-marinedrugs-18-00198]\]. *Gracilaria,* originating from Gracilariaceae family is often a source of food for many people in Malaysia \[[@B11-marinedrugs-18-00198]\]. The aqueous extract of *G. fergusonii* displayed anti-inflammatory activity at a dosage of 250 µg/ml with a percentage inhibition of 63.98% \[[@B12-marinedrugs-18-00198]\]. On the other hand, *A. anceps* originating from Lithophyllaceae family, is a red macroalga usually found in sea waters at temperatures of 5 to 15 °C. This seaweed was screened for its antagonistic activity. Data collected showed that the crude extract exhibited clear inhibition zones against several pathogens: *Yersinia* spp., *Streptococcus* spp. and *Vibrio* spp. \[[@B13-marinedrugs-18-00198]\]. However, since the existing literature is insufficient, fragmented and unsystematic, we embark on this present research to try to expand the currently limited literature.

A series of enzymes were chosen based on the current challenging diseases globally such as diabetes mellitus (DM) type II, Alzheimer's disease and skin disorders. Enzymes play a considerable role in biological reactions, contributing a diversification platform to the pharmaceutical industry. There is a wide spectrum of applicability of enzymes in the pharmaceutical industry starting from nutraceuticals, enzyme therapy, disease diagnosis, to drug synthesis \[[@B14-marinedrugs-18-00198]\]. Herein, enzymatic inhibitions involving α-amylase and α-glucosidase were investigated for DM type II, acetyl- (AChE) and butyryl-cholinesterase (BChE) for Alzheimer's disease, and tyrosinase for skin disorders. Furthermore, dysfunction of the antioxidant defensive system leads to the development of chronic health conditions related to degenerative pathologies such as cardiovascular diseases, cancer, and neurodegeneration disorders \[[@B15-marinedrugs-18-00198]\]. Thus, to prevent health complications, the body must rely on exogenous antioxidants to effectively suppress reactive oxygen species (ROS). Since seaweeds are widely consumed, it was indeed a matter of great interest for us to investigate their antioxidant properties as well.

This work was undertaken to encompass the following objectives---(1) conduct a quantitative estimation of phytochemicals using in vitro standard chemical assays and identify the compounds using ultra-high-performance liquid chromatography coupled with an electrospray ionization mass spectrometry (UHPLC-ESI-MS/MS) technique, (2) report the antioxidant capacities in terms of radical scavenging, reducing potential, metal chelating and determine the total antioxidant capacity, (3) evaluate the enzymatic inhibitory effects against clinical enzymes associated with chronic diseases, namely diabetes mellitus (α-amylase and α-glucosidase), Alzheimer's disease (AChE and BChE) and skin hyperpigmentation (tyrosinase) and (4) analyse the collected scientific data using multivariate analysis.

2. Results and Discussion {#sec2-marinedrugs-18-00198}
=========================

2.1. Antioxidant Assays {#sec2dot1-marinedrugs-18-00198}
-----------------------

As a normal protective mechanism, the human body naturally responds to oxidative stress (caused by reactive oxygen species (ROS)) using its antioxidant defence. Nevertheless, in some cases, the enzymatic systems fail to resist to ROS, and the level of antioxidants present is insufficient to successfully ascertain healthy cellular homeostasis \[[@B16-marinedrugs-18-00198],[@B17-marinedrugs-18-00198]\]. The antioxidant properties of phytochemicals are hidden behind their ability to donate electrons and/or chelate metals without them being transformed into harmful radicals \[[@B18-marinedrugs-18-00198],[@B19-marinedrugs-18-00198]\]. The search for potential antioxidant activities from marine sources is still not widespread \[[@B20-marinedrugs-18-00198]\]. Thus, to try to fill this niche, we screened the different extracts of each seaweed for their antioxidative properties.

Considering the complexity of phytochemicals, multiple assays targeting different mechanisms of action were selected to assess antioxidant properties. For instance, radical scavenging was assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS), reducing power by ferric reducing power antioxidant (FRAP) and cupric reducing antioxidant capacity (CUPRAC), total antioxidant capacity by phosphomolybdenum (PHPD) and metal chelating by ferrous ion chelating assay. Results are summarized in [Table 1](#marinedrugs-18-00198-t001){ref-type="table"}. Overall, the methanolic extract of *A. anceps* displayed the strongest antioxidant properties with all assays and the least potent was revealed to be methanolic extract of *Halimeda* spp. Existing work in literature reported that phenolic compounds are one of the most effective antioxidants \[[@B21-marinedrugs-18-00198]\]. Indeed, this fact was consistent with our study since *A. anceps* possessed the highest amount of phenolic content explaining its high antioxidant capacities. Likewise, a study suggested that *A. anceps* could be an effective source of antioxidants considering its high level of algal phenolic compounds \[[@B22-marinedrugs-18-00198]\].

Metals are entwined in our body in a very complex way. They help in the normal functioning of the body; however, an imbalance in the level of metals can lead to health complications. For instance, an excess of iron reduces hepatic extraction and metabolism of insulin leads to peripheral hyperinsulinemia causing an increase in oxidative stress which affects the normal function of insulin, hence resulting in an increase in blood glucose level \[[@B23-marinedrugs-18-00198]\]. Thus, iron chelation could be an effective therapeutic approach. As shown in [Table 1](#marinedrugs-18-00198-t001){ref-type="table"}, the ferrous ion chelating ability decreased in the following order: *A. anceps* \> *V. pachynema \> S. hypnoides \> Halimeda* spp. \> *G. fergusonii*, with the latter showing no activity. Radical scavenging activity estimations of the five seaweeds were evaluated using DPPH and ABTS radicals due to their simplicity, sensitivity, speed, stability of the radicals and cheap instrumentation \[[@B24-marinedrugs-18-00198]\]. Results from the assays showed that the methanolic extract of *A. anceps* was the best DPPH and ABTS scavenger (4.43 ± 0.07 and 18.56 ± 0.10 mg TE/g, respectively) while the extract of *Halimeda* spp. displayed the least scavenging effect with both DPPH and ABTS radicals (2.33 ± 0.04 and 5.36 ± 0.47 mg TE/g, respectively).

Furthermore, data gathered in this study showed that the crude methanolic extract of *A. anceps* possessed the most potent reducing power towards both Fe (III) and Cu (II) with Trolox equivalent values of 13.99 ± 0.30 and 46.47 ± 1.60 mg TE/g, respectively. However, *G. fergusonii* extract displayed weaker reducing potential against Cu (II) with 7.31 ± 0.07 mg TE/g, and *Halimeda* spp. extract was least potent on the reduction of Fe (III) with 4.91 ± 0.05 mg TE/g. The quantitative determination of total antioxidant capacity is based on the reduction of Mo (VI) to Mo (V) by the extract to form a green phosphate/Mo (V) complex under acidic condition \[[@B25-marinedrugs-18-00198]\]. Again, *A. anceps* extract with values of 0.73 ± 0.06 mmol TE/g demonstrated the optimal antioxidant capacity succeeded by *S. hypnoides* extract (0.37 ± 0.02 mmol TE/g), *V. pachynema* extract (0.30 ± 0.04 mmol TE/g), *G. fergusonii* extract (0.23 ± 0.01 mmol TE/g) and *Halimeda* spp. extract (0.21 ± 0.01 mmol TE/g) ([Table 1](#marinedrugs-18-00198-t001){ref-type="table"}).

2.2. Enzymatic Inhibitory Properties {#sec2dot2-marinedrugs-18-00198}
------------------------------------

The World Health Statistics 2019, an annual compilation of the World Health Organization (WHO), stated that the world is constantly under health challenges with 40 leading causes of death including ischemic heart disease, Alzheimer's disease, lung, liver, stomach, oesophagus and prostate cancer, chronic obstructive pulmonary disease, and stroke, among others \[[@B26-marinedrugs-18-00198]\]. The world is unhealthy, and our existing medications are either insufficient or ineffective. Thus, our fight against these chronic pathologies should be ongoing with new strategies on how to manage these diseases. One of the strategies currently considered by many researchers is to search for potent and more effective medications from plants. Currently, the marine ecosystem is a crucial source of medicinally important metabolites with pharmaceutical importance \[[@B27-marinedrugs-18-00198]\]. This present work is considered as second-to-none since we have screened the methanolic crude extracts of five different seaweeds, namely *Halimeda* spp., *S. hypnoides, V. pachynema, G. fergusonii* and *A. anceps* with regard to five key enzymes involved in chronic health complications. Inhibition of enzymes may be considered as a therapeutic approach; for instance, acetyl- (AChE) and butyryl-cholinesterase (BChE) inhibition: Alzheimer's disease, α-amylase and α-glucosidase inhibition: diabetes mellitus, and tyrosinase inhibition: skin disorders.

Results are summarized in [Table 2](#marinedrugs-18-00198-t002){ref-type="table"}. In terms of enzymatic properties, *A. anceps* extract significantly depressed BChE activity (IC~50~ = 6.68 ± 0.83 mg/mL) but weakly inhibited AChE activity (IC~50~ = 3.90 ± 0.83 mg/mL). Instead, the seaweed *Halimeda spp.* crude extract exhibited higher BChE inhibitory effect with IC~50~ value of 3.07 ± 0.10 mg/mL. AChE catalyses the hydrolysis of acetylcholine (ACh) into acetic acid and choline while BChE is responsible for ACh homeostasis \[[@B28-marinedrugs-18-00198]\]. However, an accumulation of ACh in synapses may result in muscarinic and nicotinic toxicity which subsequently cause muscle cramps, blurry vision, lacrimation, muscular weakness, and paralysis \[[@B29-marinedrugs-18-00198]\]. From this perspective, it is important to maintain a healthy ACh homeostasis in the body. Interestingly, it is noteworthy to highlight that BChE activity increases with the severity of dementia, thus from this background information it can be stated that searching for potent BChE inhibitors is of utmost importance, as demonstrated by the extracts of *Halimeda spp.* and *A. anceps* \[[@B30-marinedrugs-18-00198]\].

Diabetes is on the rise; since 1980, the number of patients with diabetes has increased four-fold to 422 million people irrespective of their age and gender \[[@B31-marinedrugs-18-00198]\]. Thus, there is still an urgent need to develop more efficient medications with lesser side effects. Results collected herein reported that the crude extract of *A. anceps* showed similar inhibitory effects against α-amylase (IC~50~ = 5.34 ± 0.14 mg/mL) and α-glucosidase (IC~50~ = 5.64 ± 1.19 mg/mL). On the other hand, *V. pachynema* extract demonstrated a higher inhibition against α-glucosidase (IC~50~ = 2.57 ± 0.02 mg/mL) in contrast to α-amylase (IC~50~ = 7.02 ± 0.28 mg/mL). Interestingly, pronounced inhibition of α-glucosidase is usually preferred over moderate α-amylase inhibition to develop antihyperglycemic agents with lesser gastrointestinal discomfort due to undigested carbohydrates \[[@B32-marinedrugs-18-00198]\].

The inhibitory effects of *Halimeda spp.*, *S. hypnoides, V. pachynema, G. fergusonii* and *A. anceps* extracts on tyrosinase enzyme were also evaluated. Tyrosinase is a copper-containing enzyme responsible for the process of converting [l]{.smallcaps}-tyrosine and 3,4-dihydroxyphenylalanine ([l]{.smallcaps}-DOPA) to melanin through the formation of dopaquinone. It is reported that excessive production of dopaquinone in the brain causes neurodegeneration and cell mortality. These disorders are the primary cause and the hallmark of Parkinson's and Huntington's disease \[[@B33-marinedrugs-18-00198]\]. Inhibition of tyrosinase may be considered as a therapeutic approach for managing skin disorders and more complicated diseases. Our present study showed that the crude methanolic extracts of the five seaweeds displayed relatively the same tyrosinase activity. For instance, the extract of *V. pachynema* exhibited IC~50~ value of 3.68 ± 0.03 mg/mL, *Halimeda spp.*: 3.70 ± 0.06 mg/mL, *S. hypnoides*: 3.73 ± 0.04 mg/mL, *G. fergusonii* 3.7. ± 0.05 mg/mL and *A. anceps:* 4.49 ± 0.15 mg/mL.

2.3. Bioactive Composition {#sec2dot3-marinedrugs-18-00198}
--------------------------

The ongoing quest to discover novel natural bioactive compounds remains of utmost importance for a world which is currently facing multiple health challenges. It is highly acknowledged that plants, culinary herbs or even spices are incorporated with a myriad of phytochemicals possessing medicinal values. Phytoconstituents are known to minimize the risk of chronic and inflammatory conditions \[[@B34-marinedrugs-18-00198]\]. Interestingly, a recent review compiled by Gnanavel et al. reported that more than 15,000 bioactive metabolites have been identified from marine sources and seaweeds are among them \[[@B35-marinedrugs-18-00198]\]. Among the different classes of phytochemicals, polyphenols or phenolic compounds and flavonoids are the two most widely studied classes of bioactive compounds \[[@B36-marinedrugs-18-00198]\]. Thus, in our present study, we screened the investigated seaweed extracts *Halimeda* spp., *S. hypnoides*, *V. pachynema*, *G. fergusonii* and *A. anceps* for phenolic and flavonoid contents.

Among the tested seaweeds, *A. anceps* possessed the highest phenolic content (7.83 ± 0.08 mg GAE/g) while *Halimeda* spp. yielded the lowest amount (2.24 ± 0.06 mg GAE/g). In terms of flavonoid content, *V. pachynema* yielded the highest amount, succeeded by *A. anceps*, *S. hypnoides*, *Halimeda* spp. and *G. fergusonii* (4.30 ± 0.29, 2.47 ± 0.22, 2.45 ± 0.16, 1.74 ± 0.08 and 0.42 ± 0.04 mg RE/g, in order of magnitude).

To have an overview of the chemical diversity possessed by each seaweed, an extensive profiling technique, ultra-high-performance liquid chromatography coupled with electrospray ionization mass spectrometry (UHPLC-ESI-MS/MS), was used. The results are summarized in [Table 3](#marinedrugs-18-00198-t003){ref-type="table"}. Results showed that *A. anceps* possessed a greater diversity of compounds (23) in contrast to *V. pachynema* (19), *G. fergusonii* (11), *S. hypnoides* (10) and *Halimeda* spp. (9). However, three compounds remain unidentified in *A. anceps* and two in *Halimeda* spp.

In the nontargeted analysis, we tried to identify all components present in the samples using UHPLC-ESI-MS/MS. Using HPLC-single stage Orbitrap MS, a broad spectrum of chemical classes could be separated and detected within 70 minutes. High resolution (35000) and high mass accuracy (\<5 ppm) enabled identification of most compounds. Structural identification and characterization were carried out on the comparisons of their chromatographic and ESI-MS/MS data (retention time, exact mass and fragmentation pathway) with the corresponding standards and data reported in the previous literature. Loliolide, phenolic acids, C9-C20 carboxylic acids, amino acids and their derivatives, terpenes were identified in the extracts, but their number was quite different.

### 2.3.1. *Halimeda* spp. {#sec2dot3dot1-marinedrugs-18-00198}

Three carboxylic acids were detected in negative ion mode. Compounds with a retention time of 13.50 had \[M − H\]^−^ ion at *m/z* 201.11268 (C~10~H~18~O~4~) suggesting one unsaturated bond in the aliphatic chain and they yielded a characteristic fragment ion at *m*/*z* 183.1017 corresponding to neutral loss of one water molecule ([Table 3](#marinedrugs-18-00198-t003){ref-type="table"}). 3-Methyladipic acid with a retention time of 17.32 is a well-known and characterized compound. Carboxylic acid with a retention time of 19.73 exhibited a molecular ion \[M − H\]^−^ at *m*/*z* 214.93438 ([Figure S1 in the Supplementary Information](#app1-marinedrugs-18-00198){ref-type="app"}). The isotopic pattern indicated the presence of one bromo atom in the compound and a fragment ion \[M -- H − 44\]^−^ at *m*/*z* 170.9440 corresponding to loss of CO~2~. Two monoterpenoid lactones: loliolide and isololiolide were detected in positive ion mode \[M + H\]^+^ at *m/z* 197.11777. Their structures were identified by comparison of their mass spectra with previously reported values. Ions at *m/z* 179.1069 and *m/z* 111.92 confirmed the loss of H~2~O \[M + H − H~2~O\]^+^, and also the loss of the ring adjacent to the lactone \[M + H − H~2~O − C~5~H~8~\]^+^. In addition to caulerpin, we have detected another compound at *m/z* 399.13449, but the fragmentation of this unidentified alkaloid was different from caulerpin.

### 2.3.2. *Spyridia hypnoides* {#sec2dot3dot2-marinedrugs-18-00198}

In this species, we have identified several well-known and characterized compounds, for example, pantothenic acid, 3-phenyllactic acid, riboflavin or lumichrome, loliolide and isololiolide were also present in this species ([Table 3](#marinedrugs-18-00198-t003){ref-type="table"}).

### 2.3.3. *Valoniopsis pachynema* {#sec2dot3dot3-marinedrugs-18-00198}

We also detected loliolide and isololiolide in this species. In addition to some known compounds, we detected two carboxylic acids with retention times 35.38 and 35.87 ([Table 3](#marinedrugs-18-00198-t003){ref-type="table"}). These compounds had the same \[M − H\]^−^ molecular ions at *m/z* 201.14907 (C~11~H~22~O~3~) ([Figures S2 and S3 in the Supplementary Information](#app1-marinedrugs-18-00198){ref-type="app"}). In the MS2 spectrums we did not find water losses suggesting the presence of omega hydroxyl group or ether bond. We tentatively identified these two compounds as ω-hydroxyundecanoic acid isomers. In the case of compound 19 in [Table 3](#marinedrugs-18-00198-t003){ref-type="table"} the situation was the same. We did not find water loss and the main fragment was *m/z* 59.0123 (CH~3~-COO^−^), so we tentatively identified this carboxylic acid as a ω-hydroxydodecanoic acid isomer.

### 2.3.4. *Gracilaria fergusonii* {#sec2dot3dot4-marinedrugs-18-00198}

In this species, we have identified several compounds that we have already found in the previous algae. Besides these compounds, we have identified a terpene with molecular ion at *m/z* 199.13342 in the positive ionisation mode ([Table 3](#marinedrugs-18-00198-t003){ref-type="table"}). The fragmentation of this molecule was very similar to loliolide and isololiolide, but the compound and most of its fragments had two hydrogen atoms more related to loliolide. Based on the exact molecular mass and the similarity of the fragmentation to loliolide, we tentatively identified this compound as dihydrololiolide or dihydroisololiolide.

### 2.3.5. *Amphiroa anceps* {#sec2dot3dot5-marinedrugs-18-00198}

In addition to some known and characterized compounds, we have detected three terpenes with molecular ions *m/z* 181.12285 (C~11~H~16~O~2~), 199.13340 (C~11~H~18~O~3~) and 335.22223 (C~20~H~30~O~4~), respectively, in the positive ionisation mode ([Figure S4 in the Supplementary Information](#app1-marinedrugs-18-00198){ref-type="app"}). Compound 18 yielded characteristic fragment ions at *m/z* 163.1119 and 145.1014 corresponding to neutral loss of two water molecules. Compounds 19 and 20 yielded characteristic fragment ions at *m/z* 181.1224, 163.1117, 145.1013 and 317.2114, 299.2008, 281.1904, respectively, matching a neutral loss of three water molecules ([Table 3](#marinedrugs-18-00198-t003){ref-type="table"}).

2.4. Multivariate Analysis {#sec2dot4-marinedrugs-18-00198}
--------------------------

The unsupervised multivariate analysis, principal component analysis (PCA) and Hierarchical cluster analysis (HCA) were used to comprehensively screen trends or resemblance between samples, i.e., whether they clustered according to the evaluated biological activities and to identify the key biological activities that contribute to the explanation of most the variance in the dataset. PCA aims to reduce the dimensionality of the data through summarizing as much information as possible. As shown in the PCA score plot, *A. anceps* was effectively discriminated from the other species (*V. pachynema*, *G. fergusonii*, *Halimena* spp., and *S. hypnoides*) ([Figure 1](#marinedrugs-18-00198-f001){ref-type="fig"}A). In more detail, this segregation was done along the first component that was defined as the linear combination of seven biological activities (PPBD, tyrosinase, ABTS, CUPRAC, FRAP, metal chelating ability (MCA), α-amylase) ([Figure 1](#marinedrugs-18-00198-f001){ref-type="fig"}C). Alongside this, the clustered image map (CIM) displayed a good classification of the samples into two distinct groups ([Figure 1](#marinedrugs-18-00198-f001){ref-type="fig"}B). CIM was based on the hierarchical clustering simultaneously operating on the use of "Euclidean" distance and "Ward" linkage method. The HCA result was consistent with the principal component analysis, indicating the seven biological activities mentioned above effectively characterize the differences between *A. anceps* and the other species. Additionally, biological activities recorded for *A. anceps* were most potent among all the studied seaweeds, suggesting *A. anceps* as the most bioactive species.

3. Materials and Methods {#sec3-marinedrugs-18-00198}
========================

3.1. Materials and Extraction {#sec3dot1-marinedrugs-18-00198}
-----------------------------

The five seaweeds, namely *Halimeda* spp., *Spyridia hypnoides* (Bory de Saint-Vincent) Papenfuss, *Valoniopsis pachynema* (G. Martens) Børgesen, *Gracilaria fergusonii* J. Agardh and *Amphiroa anceps* (Lamarck) Decaisne were collected from Mandapam coast, Gulf of Mannar, Tamil Nadu, India during March 2018. The collected seaweeds were identified by Dr. R. Arumugam, Department of Botany, A. V. C. College, Mannampanthal, Tamil Nadu, India. The collected sample was brought to the laboratory and washed thoroughly with tap water to remove all the extraneous materials and shade dried. The extracts were prepared as described in a previous study \[[@B37-marinedrugs-18-00198]\].

3.2. Determination of Antioxidant and Enzyme Inhibitory Effects {#sec3dot2-marinedrugs-18-00198}
---------------------------------------------------------------

The radical scavenging (1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid (ABTS)), reducing power (cupric ion reducing activity (CUPRAC), ferric reducing antioxidant power (FRAP)), total antioxidant capacity (phosphomolybdenum (PHPD)) and metal chelating power using ferrous ions were conducted to evaluate antioxidant properties. Acetylcholinesterase (AChE), butyrylcholinesterase (BChE), α-amylase, α-glucosidase and tyrosinase were used to evaluate enzymatic inhibitory properties.

Antioxidant abilities were evaluated as standard equivalents (trolox (TE, for ABTS, DPPH, FRAP, CUPRA and PHPD) and EDTA (EDTAE, for metal chelating)). Enzyme inhibitory assays results were expressed as IC~50~ values. Galantamine (GALAE, for cholinesterase), kojic acid (KAE, for tyrosinase), acarbose (ACAE, for amylase and glucosidase) were used as standard inhibitors in the enzyme assays. The detailed experimental procedures were given in the [Supplementary Information](#app1-marinedrugs-18-00198){ref-type="app"} as mentioned by our previous papers \[[@B38-marinedrugs-18-00198],[@B39-marinedrugs-18-00198]\]. The detailed experimental procedures were given in the [Supplementary File](#app1-marinedrugs-18-00198){ref-type="app"}.

3.3. Profiling of Bioactive Metabolites Using Ultra Performance High-Pressure Liquid Chromatography (UHPLC) {#sec3dot3-marinedrugs-18-00198}
-----------------------------------------------------------------------------------------------------------

Dionex Ultimate 3000RS HPLC instrument was used to analyse the phytochemical composition of the extracts. Before RP-HPLC analysis, the extracts were filtered through 0.22 μm PTFE filter membrane (Labex Ltd., Hungary). The filtered samples were injected onto a Thermo Accucore C18 (100 mm × 2, i.d., 2.6 μm) column thermostated at 25 °C (±1 °C). The solvents used were water (A) and methanol (B). Both were acidified with 0.1% formic acid. The flow rate was maintained at 0.2 mL min^−1^. The elution gradient was isocratic 5% B (0--3 min), a linear gradient increasing from 5% B to 100% (3--43 min), 100% B (43--61 min), a linear gradient decreasing from 100% B to 5% (61--62 min) and 5% B (62--70 min). The column was coupled with a Thermo Q Exactive Orbitrap mass spectrometer (Thermo Scientific, USA) equipped with electrospray ionization source. Spectra were recorded in positive- and negative-ion mode, respectively, between *m*/*z* 100 and 1500.

The TraceFinder 3.1 (Thermo Scientific, USA) software was used for nontargeted screening. Most of the compounds were identified based on literature data and/or our previously published works. All cases, retention time, exact molecular mass, isotopic pattern, essential fragments with a given (5 ppm) mass tolerance were used for the identification of the compounds. Peaks that were detected in blank runs and those were also detected in the samples were rejected. Compounds which were confirmed by standards are marked in [Table 2](#marinedrugs-18-00198-t002){ref-type="table"}.

3.4. Statistical Analysis {#sec3dot4-marinedrugs-18-00198}
-------------------------

All the data were given as mean ± SD and the statistical procedures were performed using R software v. 3.5.1. One-way ANOVA followed by Tukey's multiple range was conducted to measure differences (*p* \< 0.05) between the tested samples. Principal component analysis (PCA) and hierarchical cluster analysis (HCA) were performed to evaluate the differences of the tested seaweeds in terms of biological activities.

4. Conclusions {#sec4-marinedrugs-18-00198}
==============

The present study highlights for the first time the phytochemical profile, antioxidant capacities and enzyme inhibitory properties of five seaweeds. The seaweeds showed low to moderate antioxidant and enzymatic activities, with *A. anceps* showing the highest antioxidant properties, attributed to its high level of phenolics compounds. Hence, *A. anceps* could be considered as an effective source of natural antioxidants which deserves further consideration. This observation was further supported via multivariate analysis. *Halimeda* spp. was the least potent seaweed in terms of antioxidant and enzymatic properties but with potent anti-tyrosinase activity which needs further attention. The presence of loliolide compound in all of the five seaweeds warrants further investigations particularly in terms of cytotoxicity analysis and bioavailability. This study has established baseline data on these seaweeds which could be further explored for potential sustainable development of novel bioproducts.

This paper was supported by KU Brain Pool Program of the Konkuk University, Seoul, South Korea.
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The following are available online at <https://www.mdpi.com/1660-3397/18/4/198/s1>, Figure S1: Extracted Ion Chromatogram (XIC) of compound 7 in *Halimeda* spp. at m/z 214.93438 (A) MS2 spectrum of compound 7 in *Halimeda* spp (B). Compound details available in [Table 2](#marinedrugs-18-00198-t002){ref-type="table"}. Figure S2: Extracted Ion Chromatogram (XIC) of compounds 10 and 12 in *Valoniopsis pachynema* at m/z 197.11777 (A). MS2 spectrum of compound 12 in *Valoniopsis pachynema* (B). Compounds details available in [Table 2](#marinedrugs-18-00198-t002){ref-type="table"}. Figure S3: Extracted Ion Chromatogram (XIC) of compounds 17 and 18 in *Valoniopsis pachynema* at m/z 201.14907 (A). MS2 spectrum of compound 18 in *Valoniopsis pachynema* (B). Compounds details available in [Table 2](#marinedrugs-18-00198-t002){ref-type="table"}. Figure S4: Extracted Ion Chromatogram (XIC) of compounds 20 in *Amphiroa anceps* at m/z 335.22223 (A). MS2 spectrum of compound 20 in *Amphiroa anceps* (B). Compounds details available in [Table 2](#marinedrugs-18-00198-t002){ref-type="table"}. The detailed experimental procedures for antioxidant and enzyme inhibitory bioassays were given in supplementary file.
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marinedrugs-18-00198-t001_Table 1

###### 

Antioxidant properties of the tested seaweed extracts. \*

  -------------------------------------------------------------------------------------------------------------------------------------
  Assays               *Halimeda* spp.   *Spyridia hypnoides*   *Valoniopsis pachynema*   *Gracilaria fergusonii*   *Amphiroa anceps*
  -------------------- ----------------- ---------------------- ------------------------- ------------------------- -------------------
  DPPH (mg TE/g)       2.33 ± 0.04e      2.55 ± 0.05d           2.68 ± 0.03c              3.83 ± 0.09b              4.43 ± 0.07a

  ABTS (mg TE/g)       5.36 ± 0.47e      8.91 ± 0.30d           11.27 ± 1.07c             13.26 ± 0.45b             18.56 ± 0.10a

  CUPRAC (mg TE/g)     9.47 ± 0.17c      10.95 ± 0.20c          25.71 ± 0.73b             7.31 ± 0.07d              46.47 ± 1.60a

  FRAP (mg TE/g)       4.91 ± 0.05d      6.27 ± 0.10c           9.03 ± 0.10b              5.24 ± 0.14d              13.99 ± 0.30a

  PHPD (mmol TE/g)     0.21 ± 0.01c      0.37 ± 0.02b           0.30 ± 0.04bc             0.23 ± 0.01c              0.73 ± 0.06a

  Chelating ability\   1.62 ± 0.15d      6.07 ± 0.56c           9.05 ± 0.76b              NA                        16.99 ± 0.11a
  (mg EDTAE/g)                                                                                                      
  -------------------------------------------------------------------------------------------------------------------------------------

\* Values are expressed as mean ± S.D. EDTAE, EDTA equivalent; PHPD, phosphomolybdenum assay; NA, not active. Different letters indicate significant differences in the extracts (*p* \< 0.05).

marinedrugs-18-00198-t002_Table 2

###### 

Enzyme inhibitory effects (IC~50~ = mg/mL) of the tested seaweed extracts. \*

  Assays                    AChE              BChE              Tyrosinase     Alpha-Amylase   Alpha-Glucosidase
  ------------------------- ----------------- ----------------- -------------- --------------- -------------------
  *Halimeda* spp.           3.07 ± 0.10a      7.82 ± 0.67a      3.70 ± 0.06b   8.19 ± 0.23a    3.20 ± 0.31b
  *Spyridia hypnoides*      3.18 ± 0.05a      7.96 ± 1.01a      3.73 ± 0.04b   7.31 ± 0.36b    4.11 ± 0.40a
  *Valoniopsis pachynema*   3.25 ± 0.06a      8.75 ± 1.31a      3.68 ± 0.03b   7.02 ± 0.28b    2.57 ± 0.02c
  *Gracilaria fergusonii*   3.27 ± 0.10a      7.43 ± 1.00a      3.70 ± 0.05b   8.27 ± 0.17a    4.90 ± 0.33a
  *Amphiroa anceps*         3.90 ± 0.83a      6.68 ± 0.83a      4.49 ± 0.15a   5.34 ± 0.14c    5.64 ± 1.19a
  Galantamine               0.003 ± 0.0001b   0.004 ± 0.0001b   NT             NT              NT
  Kojic acid                NT                NT                0.09 ± 0.01c   NT              NT
  Acarbose                  NT                NT                NT             0.50 ± 0.01d    0.75 ± 0.02d

\* Values are expressed as mean ± S.D. NT: not tested. Different letters indicate significant differences in the extracts (*p* \< 0.05).

marinedrugs-18-00198-t003_Table 3

###### 

Chemical composition of five seaweeds.

  No.                       Name                                               Formula              R*t*    \[M + H\]^+^   \[M − H\]^−^   Fragment 1   Fragment 2   Fragment 3   Fragment 4   Fragment 5
  ------------------------- -------------------------------------------------- -------------------- ------- -------------- -------------- ------------ ------------ ------------ ------------ ------------
  *Halimeda* spp.                                                                                                                                                                             
  1                         Acetylcholine                                      C~7~H~15~NO~2~       1.20    146.11810                     87.0446      60.0816                                
  2                         Unidentified hydroxycarboxylic acid                C~10~H~18~O~4~       13.50                  201.11268      183.1017     57.1221      139.1116                  
  3                         Hydroxyethylimino-phenylpropanol derivative        C~11~H~15~NO~2~      17.08   194.11810                     176.1072     152.1071     134.0967     117.0702     91.0547
  4                         3-Methyladipic acid                                C~7~H~12~O~4~        17.32                  159.06574      141.0544     115.0750     97.0642                   
  5                         Loliolide or isololiolide                          C~11~H~16~O~3~       18.19   197.11777                     179.1068     161.0962     135.1171     133.1014     107.0859
  6                         Loliolide or isololiolide                          C~11~H~16~O~3~       19.47   197.11777                     179.1069     161.0963     135.1170     133.1014     107.0860
  7                         Bromocarboxylic acid                               C~7~H~5~BrO~3~       19.73                  214.93438      170.9440     78.9173                                
  8                         Caulerpin                                          C~24~H~18~N~2~O~4~   34.52   399.13449                     385.1174     367.1080     340.1209     308.0944     280.0995
  9                         Unidentified alkaloid                              C~24~H~18~N~2~O~4~   37.16   399.13449                     363.1574                                            
  *Spyridia hypnoides*                                                                                                                                                                        
  1                         Pantothenic acid                                   C~9~H~17~NO~5~       5.16    220.11850                     202.1076     184.0971     174.1123     116.0346     90.0555
  2                         3-(4-Hydroxyphenyl) lactic acid                    C~9~H~10~O~4~        8.93                   181.05009      163.0392     135.0441     119.0491     72.9917      
  3                         Kynurenic acid isomer                              C~10~H~7~NO~3~       14.34   190.05042                     162.0550     144.0445     116.0498                  
  4                         3-Phenyllactic acid                                C~9~H~10~O~3~        16.84                  165.05517      147.0438     119.0489     72.9915                   
  5                         3-Methyladipic acid                                C~7~H~12~O~4~        17.33                  159.06574      141.0546     115.0750     97.0645                   
  6                         Loliolide or isololiolide                          C~11~H~16~O~3~       18.18   197.11777                     179.1069     161.0962     135.1171     133.1014     107.0859
  7                         Riboflavin                                         C~17~H~20~N~4~O~6~   18.60   377.14611                     359.1344     243.0879     200.0819     172.0869     99.0444
  8                         Loliolide or isololiolide                          C~11~H~16~O~3~       19.46   197.11777                     179.1069     161.0962     135.1171     133.1014     107.0860
  9                         N-(2-Phenylethyl) acetamide                        C~10~H~13~NO         20.00   164.10754                     122.0967     105.0703     90.9482      79.0548      
  10                        Lumichrome                                         C~12~H~10~N~4~O~2~   23.88   243.08821                     216.0768     200.0825     198.0665     172.0871     
  *Valoniopsis pachynema*                                                                                                                                                                     
  1                         Betaine                                            C~5~H~11~NO~2~       1.22    118.08681                     59.0737      58.0659                                
  2                         Ectoine                                            C~6~H~10~N~2~O~2~    1.22    143.08206                     101.0715     97.0766      73.0768      68.0502      56.0502
  3                         Acetylcholine                                      C~7~H~15~NO~2~       1.23    146.11810                     87.0446      60.0816                                
  4                         Pantothenic acid                                   C~9~H~17~NO~5~       5.17    220.11850                     202.1078     184.0972     174.1123     116.0347     90.0555
  5                         4-Hydroxybenzoic acid                              C~7~H~6~O~3~         8.99                   137.02387      93.0330      65.0382                                
  6                         Kynurenic acid                                     C~10~H~7~NO~3~       13.02   190.05042                     162.0551     144.0445     116.0495     89.0386      
  7                         Kynurenic acid isomer                              C~10~H~7~NO~3~       14.33   190.05042                     162.0549     144.0446     116.0496                  
  8                         Methyladipic acid isomer                           C~7~H~12~O~4~        15.04                  159.06574      141.0544     115.0750     97.0644                   
  9                         3-Phenyllactic acid                                C~9~H~10~O~3~        16.82                  165.05517      147.0440     119.0487     72.9914                   
  10                        Loliolide or isololiolide                          C~11~H~16~O~3~       18.19   197.11777                     179.1070     161.0963     135.1171     133.1015     107.0860
  11                        Azelaamic acid (9-Amino-9-oxononanoic acid)        C~9~H~17~NO~3~       18.64                  186.11302      125.0958     123.0803     97.0645                   
  12                        Loliolide or isololiolide                          C~11~H~16~O~3~       19.46   197.11777                     179.1069     161.0962     135.1171     133.1015     107.0860
  13                        Chicoric acid (2,3-Di-*O*-caffeoyltartaric acid)   C~22~H~18~O~12~      19.53                  473.07201      311.0414     293.0303     219.0298     179.0340     149.0080
  14                        N-(2-Phenylethyl) acetamide                        C~10~H~13~NO         19.99   164.10754                     122.0967     105.0704     90.9483      79.0549      
  15                        Hydroxycapric acid                                 C~10~H~20~O~3~       33.27                  187.13342      141.1270     59.0123                                
  16                        Caulerpin                                          C~24~H~18~N~2~O~4~   34.51   399.13449                     385.1177     367.1078     340.1208     308.0943     280.0998
  17                        Hydroxyundecanoic acid isomer 1                    C~11~H~22~O~3~       35.38                  201.14907      59.0123                                             
  18                        Hydroxyundecanoic acid isomer 2                    C~11~H~22~O~3~       35.87                  201.14907      59.0123                                             
  19                        Hydroxydodecanoic acid                             C~12~H~24~O~3~       38.04                  215.16472      169.1581     59.0123                                
  *Gracilaria fergusonii*                                                                                                                                                                     
  1                         Gigartinine                                        C~7~H~15~N~5~O~3~    1.20    218.12532                     133.0973     116.0709     115.0869     86.0354      70.0657
  2                         Phenethylamine                                     C~8~H~11~N           3.67    122.09698                     105.0703     103.0548     79.0548                   
  3                         Methyladipic acid isomer                           C~7~H~12~O~4~        15.03                  159.06574      141.0547     115.0750     97.0645                   
  4                         3-Phenyllactic acid                                C~9~H~10~O~3~        16.82                  165.05517      147.0440     119.0488     72.9915                   
  5                         Loliolide or isololiolide                          C~11~H~16~O~3~       18.17   197.11777                     179.1069     161.0961     135.1171     133.1014     107.0859
  6                         Loliolide or isololiolide                          C~11~H~16~O~3~       19.46   197.11777                     179.1069     161.0962     135.1170     133.1014     107.0860
  7                         Chicoric acid (2,3-Di-*O*-caffeoyltartaric acid)   C~22~H~18~O~12~      19.53                  473.07201      311.0414     293.0303     219.0298     179.0340     149.0080
  8                         N-(2-Phenylethyl) acetamide                        C~10~H~13~NO         19.98   164.10754                     122.0967     105.0703     90.9482      79.0549      
  9                         Lumichrome                                         C~12~H~10~N~4~O~2~   23.88   243.08821                     216.0772     200.0819     198.0671     172.0869     
  10                        Dihydrololiolide or dihydroisololiolide            C~11~H~18~O~3~       30.06   199.13342                     181.1225     163.1118     153.1275     135.1170     107.0859
  11                        Hydroxydodecanoic acid                             C~12~H~24~O~3~       38.04                  215.1647       169.1595     59.0123                                
  *Amphiroa anceps*                                                                                                                                                                           
  1                         3-(4-Hydroxyphenyl) lactic acid                    C~9~H~10~O~4~        9.01                   181.05009      163.0386     135.0441     119.0487     72.9916      
  2                         Methyladipic acid isomer                           C~7~H~12~O~4~        15.07                  159.06574      141.0546     115.0750     97.0644                   
  3                         N-Acetylisoleucine                                 C~8~H~15~NO~3~       15.92                  172.09737      130.0860     128.1068                               
  4                         N-Acetylleucine                                    C~8~H~15~NO~3~       16.75                  172.09737      130.0860     128.1068                               
  5                         3-Phenyllactic acid                                C~9~H~10~O~3~        16.85                  165.05517      147.0439     119.0489     72.9915                   
  6                         Indoleacetic acid                                  C~10~H~9~NO~2~       17.26                  174.05551      130.0649     128.0491                               
  7                         3-Methyladipic acid                                C~7~H~12~O~4~        17.36                  159.06574      141.0547     115.0750     97.0644                   
  8                         4-Coumaric acid                                    C~9~H~8~O~3~         17.72                  163.03952      119.0488     93.0331                                
  9                         Loliolide or isololiolide                          C~11~H~16~O~3~       18.20   197.11777                     179.1068     161.0961     135.1170     133.1015     107.0859
  10                        Riboflavin                                         C~17~H~20~N~4~O~6~   18.58   377.14611                     359.1341     243.0876     200.0822     172.0866     99.0445
  11                        Indole carboxaldehyde                              C~9~H~7~NO           18.91   146.06059                     118.0654     117.0577     91.0547                   
  12                        Loliolide or isololiolide                          C~11~H~16~O~3~       19.47   197.11777                     179.1068     161.0961     135.1170     133.1014     107.0859
  13                        Chicoric acid (2,3-Di-*O*-caffeoyltartaric acid)   C~22~H~18~O~12~      19.53                  473.07201      311.0414     293.0303     219.0298     179.0340     149.0080
  14                        N-(2-Phenylethyl) acetamide                        C~10~H~13~NO         20.00   164.10754                     122.0967     105.0703     90.9482      79.0549      
  15                        Caffeoyl phenylethanoid glycoside isomer 1         C~29~H~36~O~15~      21.97                  623.19760      161.0232     133.0280                               
  16                        Caffeoyl phenylethanoid glycoside isomer 2         C~29~H~36~O~15~      23.22                  623.19760      161.0232     133.0282                               
  17                        Lumichrome                                         C~12~H~10~N~4~O~2~   23.85   243.08821                     216.0768     200.0823     198.0660     172.0870     
  18                        Unidentified terpene 1                             C~11~H~16~O~2~       26.59   181.12285                     163.1119     145.1014     135.1171     121.1014     107.0859
  19                        Unidentified terpene 2                             C~11~H~18~O~3~       30.06   199.13340                     181.1224     163.1117     145.1013     135.1171     111.0443
  20                        Unidentified terpene 3                             C~20~H~30~O~4~       32.47   335.22223                     317.2114     299.2006     281.1903     273.1854     255.1740
  21 ^1^                    Eicosapentaenoic acid                              C~20~H~30~O~2~       44.57                  301.21676      257.2273     203.1801     135.1166                  
  22                        Pheophytin A                                       C~55~H~74~N~4~O~5~   62.78   871.57375                     593.2763     533.2549     460.2259                  
  23                        Pheophytin A isomer                                C~55~H~74~N~4~O~5~   64.99   871.57375                     593.2764     533.2552     459.2172                  

^1^ Confirmed by standard.

[^1]: These authors were contributed equally to this work.
